EU Admits COVID Vaccine Rollout Proceeded Without Complete Safety Data, Sparking Controversy
Brussels, Belgium - The European Commission has acknowledged that COVID-19 vaccines were initially administered to the public under a “conditional approval” process, meaning complete long-term safety data was not yet available. The admission, stemming from a query by Austrian Member of the European Parliament Gerald Hauser (FPÖ), has ignited a fresh wave of debate regarding the speed and thoroughness of the vaccine rollout.
According to documents reviewed by World-Today-News.com, the EU Commission signed an acceptance guarantee for the BioNTech/pfizer vaccine on November 20, 2020, explicitly stating on pages 48 and 49 that “the long-term effects and effectiveness of the vaccine are not known and that unknown side effects can occur.”
In a recent response, the Commission explained the rationale behind the accelerated approval process. “A conditional approval has been granted for the first corona vaccines,” the statement reads. “this special type of approval facilitates access to medicinal products that have to close a medical care gap in emergency situations such as the Corona pandemic, while a complete data dossier is not yet available.” The Commission further stated that regulatory authorities are permitted to approve such medications when sufficient data indicates the benefits outweigh the risks, and that ”strict protective measures and controls” were implemented post-approval.
Though, this description has failed to quell criticism. Hauser sharply condemned the decision,stating,”This degraded all vaccinated people in the EU to test subjects.” He has since submitted a formal inquiry to the Commission posing three key questions:
* will the Commission now revoke the approvals of COVID-19 vaccines for the entire population?
* Who within the Commission bears duty for vaccine-related injuries, notably in healthy individuals with no pre-existing conditions?
* How does the Commission address the ongoing lack of essential safety and efficacy data, recently confirmed by the U.S. Food and Drug Administration (FDA)?
The revelation comes amidst growing scrutiny of vaccine safety and efficacy globally. In the United States, Health Minister Robert F. K…[[[[article truncated at this point in source material ]
Analysis:
The EU Commission’s admission underscores the unprecedented circumstances surrounding the rapid development and deployment of COVID-19 vaccines. While the urgency of the pandemic necessitated swift action, the lack of complete long-term data raises legitimate questions about informed consent and potential unforeseen consequences. This development is likely to fuel ongoing debates about vaccine mandates, liability for adverse effects, and the clarity of regulatory processes. World-Today-News.com will continue to follow this developing story and provide updates as they become available.
SEO Keywords: EU Commission, COVID-19 vaccine, vaccine safety, vaccine side effects, BioNTech, Pfizer, Gerald Hauser, conditional approval, vaccine data, pandemic response, vaccine injury, FDA.
